Pharmacological Intervention to Modulate HDL: What Do We Target?

Pharmacological Intervention to Modulate HDL: What Do We Target?

The cholesterol concentrations of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) have traditionally served as risk factors for cardiovascular disease. As such, novel therapeutic interventions aiming to raise HDL cholesterol have been tested in the clinical setting. However, most tr...

Full description

Bibliographic Details
Main Authors: Nicholas J. Woudberg, Sarah Pedretti, Sandrine Lecour, Rainer Schulz, Nicolas Vuilleumier, Richard W. James, Miguel A. Frias
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-01-01
Series:Frontiers in Pharmacology
Subjects:
HDL
pharmaceutical intervention
HDL functionality
HDL subclass
cardiovascular disease
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00989/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00989/full

Similar Items